NautaDutilh assisted LUMICKS Technologies B.V. with its $93 million Series D financing round. The financing round was led by new investors Farallon Capital Management and Lauxera Capital Partners, ...
Op 4 februari kondigde Pharvaris N.V. de gegarandeerde emissie van nieuwe gewone aandelen voor een bedrag van USD 190 miljoen aan. De intekenprijs werd verhoogd en kwam uit boven de prijsvork. Naut...
NautaDutilh assisted biotech company Arvelle Therapeutics alongside Sidley Austin on its acquisition by Italian Biotech Angelini Pharma. The deal is the largest acquisition for the 100-year old Ang...
NautaDutilh assisted Pharvaris B.V. with its $80 million Series C financing round, bringing its total venture funding to over $160 million to date. NautaDutilh also assisted Pharvaris with its Seri...
NautaDutilh successfully assisted the new investors Novo Growth, the growth equity arm of Novo Holdings (as lead investor), Roquette Ventures and Unovis Asset Management on the EUR 22 million Serie...
NautaDutilh is proud to have worked alongside Nationale-Nederlanden to launch Woonnu, a new mortgage loan platform that offers consumer mortgage loans that rewards steps taken by the consumer to re...
NautaDutilh is pleased to have assisted Mediaocean (backed by Vista Equity Partners) with its acquisition of Symsys Software. Symsys is the leading media management software provider in the Netherl...
NautaDutilh assisted Biotech company Axovant Sciences and newly created company Arvelle Therapeutics B.V. - alongside Cooley acting as US Counsel - on acquiring the exclusive rights from SK Biophar...
Our website only uses cookies when you play video content. Video content is streamed from Vimeo. Our website does not use tracking cookies and/or third party cookies when you do not play video content. Please read the privacy/cookie policy for more information.
International Law Firm
English
